A Comparison of Metoclopramide Vs. Droperidol/Phenobarbital for Emesis Induced by Chemotherapy
- 1 February 1987
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 293 (2) , 90-93
- https://doi.org/10.1097/00000441-198702000-00004
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Combination metoclopramide and dexamethasone: an effective antiemetic regimen in outpatients receiving non-cisplatin chemotherapy.Journal of Clinical Oncology, 1984
- Intravenous MetoclopramideJAMA, 1982
- Emesis as a Critical Problem in ChemotherapyNew England Journal of Medicine, 1981
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Management of Nausea and Vomiting in the Cancer PatientJAMA, 1981
- MALLORY-WEISS LESION FOLLOWING CANCER CHEMOTHERAPYThe Lancet, 1977
- Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer ChemotherapyNew England Journal of Medicine, 1975
- Cancer Treatment Needs Better AntiemeticsNew England Journal of Medicine, 1975
- Controlled Clinical Studies of Orally Administered Antiemetic DrugsGastroenterology, 1969